ADD/ADHD Agents 1/30/2019
Alinia (Nitazoxanide) 5/27/2016
Aliskiren-Containing Agents (Except Valturna) 5/31/2016
Allergen Extracts 11/09/2018
Altabax (Retapamulin) 5/27/2016
Antiemetics 5/27/2016
Antipsychotics 1/21/2019
Anxiolytics and Sedatives/Hynotics 10/12/2018
Buprenorphine Agents 3/26/2018
Carisoprodol 11/20/2017
CNS Stimulants 01/31/2011
Copaxone (Glatiramer) 08/01/2018
Cough/Cold Medications 02/12/2018
Cyclobenzaprine 05/08/2017
Cystic Fibrosis Agents 1/30/2019
Desmopressin 05/08/2017
Dextromethorphan Overutilization 7/17/2018
Drug Regimen Optimization 04/03/2015
Dupixent 01/03/2019
Duplicate Therapy 05/06/2019
Emflaza 7/28/2017
Erythropoiesis-Stimulating Agents 10/03/2017
Fentanyl Agents 5/30/2017
Forteo 05/08/2017
GI Motility Agents 02/12/2018
GLP-1 Receptor Agonists 04/06/2018
Growth Hormone 05/11/2017
H.P. Acthar 10/12/2018
Hepatitis C Virus (Initial) 3/2018
Hepatitis C Virus (Refill) 3/2018
Imiquimod 12/10/2018
Increlex (Mecasermin) 05/08/2017
Injectable Pulmonary HTN Agents 10/11/2018
Ketorolac (Toradol) 08/11/2017
Leukotriene Modifiers 02/01/2016
Lidocaine Patches 2/15/2018
Lovaza (Omega-3-Acid Ethyl Esters) Capsules 04/03/2015
Makena 8/22/2018
Morphine Equivalent Dose (MED) Limit 1/30/2019
Opiate Overutilization 1/21/2019
Opiate/Benzodiazepine/Muscle Relaxant Combinations 1/21/2019
OxyContin (Oxycodone ER) 11/20/2017
PCSK9 Inhibitors 11/17/2016
Promethazine/Promethazine Containing Products 02/12/2018
Propylthiouracil 08/11/2017
Ranexa 11/20/2017
Savella 11/30/2015
Symlin (Pramlintide Acetate) 04/12/2018
Synagis (Palivizumab) 11/16/2018
Topical Immunomodulators 5/31/2017
VMAT2 Inhibitors 7/23/2018
Xenical (Orlistat) 1/2018
Xifaxan (Rifaximin) 04/12/2018
Xyrem 1/21/2019
Zelboraf 04/12/2018